4 penny stocks to buy right now

I’m searching for the best low-cost UK shares to buy today. And I think these top penny stocks could be brilliant shares to snap up.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I’m searching for the best penny stocks to buy for my investment portfolio. Here are four cheap UK shares I’d buy without delay.

Medical marvel

I think BATM Advanced Communications is in great shape as a long fight against Covid-19 could be on the cards. Demand for its medical testing kits is soaring as slowing vaccination numbers and virus variants cause global infection rates to tick higher again.

Revenues at the penny stock’s Bio-Medical Division soared more than 10% year-on-year between January and June. The unit now accounts for over three-quarters of group sales versus 64.6% in mid-2020.

Competition in the medical diagnostics market is intense. And BATM will have to paddle extremely hard to keep sales rising at a brisk pace. But I’m encouraged by its successes so far and would happily buy this stock today.

Property powerhouse

Assura is another healthcare-focussed penny stock I’m thinking of snapping up. This business develops, acquires and lets out primary healthcare facilities across UK. It’s also set to benefit from NHS policy which aims to divert people away from hospitals and onto external medical sites.

The long-term outlook for Assura looks quite robust as demand for such facilities should grow strongly in line with the country’s rapidly-ageing population.

Statista thinks there will be around 22.5m Britons over the age of 65 by 2050. That compares with around 16.4m last year.

I think the main risk to Assura shareholders comes through the company’s commitment to growth through acquisitions. This leaves it in danger of overpaying for an asset and performance falling short of prior expectations.

A penny stock for value lovers

The trend of people demanding more bang for their buck isn’t going to go away any time soon. The rapid expansion of grocers Aldi and Lidl, and more general retailers like The Range and B&M, illustrates the massive growth potential that this channel still offers.

And it’s why I’d buy book, board game, stationery and craft products retailer TheWorks.co.uk. Latest financials for the value retailer showed like-for-like sales (on a two-year basis) rose 13% during the 11 weeks ended 18 July.

It’s true that takings at the firm could suffer if broader consumer spending levels weaken. However, TheWorks’ focus on the low-cost end of the market could help lessen the blow.

Turkish delight

As a UK share investor, I’ve also made a point of getting exposure to emerging markets and regions where rapid population growth and increasing wealth levels offer excellent profits opportunities.

One penny stock I’d buy to ride this theme is DP Eurasia, the sole franchisee of the Domino’s Pizza fast-food brand in Turkey, Russia, Georgia, and Azerbaijan.

Group sales at the company soared almost 60% in the first half of 2021. And DP Eurasia is embarking on rapid expansion to make the most of the exploding food delivery market.

The experts at Statista think the Turkish market for example will grow 75% between now and 2025 to around $1.9bn. I think this is a top buy, despite the threat posed by fast-growing regional operators like Getir.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended B&M European Value. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »